MedPath

Magnesium sulphate for treatment of tetanus in childre

Not Applicable
Completed
Conditions
Health Condition 1: null- Tetanus
Registration Number
CTRI/2018/01/011252
Lead Sponsor
o sponsor investigator initiated trial
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
27
Inclusion Criteria

All consecutive patients (sample size 30) admitted to the PICU with a clinical diagnosis of tetanus were enrolled after taking informed consent.

Exclusion Criteria

patients with renal dysfunction ie S. creatinine >1mg/dL or urine output <1mg/kg/hour were excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath